Evaluation of a steroid releasing sinus implant for the treatment of patients undergoing frontal sinus surgery for chronic rhinosinusitis

References

• Halawi AM, Smith SS, Chandra RK. Chronic rhinosinusitis: epidemiology andcost. Allergy Asthma Proc. 2013 Jul-Aug;34(4):328–334. PubMed PMID: 23883597. DOI:10.2500/aap.2013.34.3675.Review
   PubMed Web of Science ®Google Scholar
• Bhattacharyya N. Ambulatory sinus and nasal surgery in the United States: demographics and perioperative outcomes. Laryngoscope. 2010 Mar;120(3):635–638.
   PubMed Web of Science ®Google Scholar
• Svider PF, Sekhsaria V, Cohen DS, et al. Geographic and temporal trends in frontal sinus surgery. Int Forum Allergy Rhinol. 2015 Jan;5(1):46–54. Epub 2014 Nov 3. DOI:10.1002/alr.21425
   PubMed Web of Science ®Google Scholar
• Pham V, Sykes K, Wei J. Long-term outcome of once daily nasal irrigation forthe treatment of pediatric chronic rhinosinusitis. Laryngoscope. 2014 Apr;124(4):1000–1007. Epub 2013 Dec 6. DOI:10.1002/lary.24224
   PubMed Web of Science ®Google Scholar
• Chong LY, Head K, Hopkins C, et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016 Apr 26;4:CD011995.
   PubMedGoogle Scholar
• Chong LY, Head K, Hopkins C, et al. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016 Apr 26;4:CD011996.
   PubMedGoogle Scholar
• Stjärne P, Mösges R, Jorissen M, et al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg. 2006;132:179.
   PubMedGoogle Scholar
• Albu S. Novel drug-delivery systems for patients with chronic rhinosinusitis. Drug Des Devel Ther. 2012;6:125–132. Epub 2012 May 31. Review. DOI:10.2147/DDDT.S25199
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012 Mar;(23):3 p preceding table of contents, 1-298.
   PubMedGoogle Scholar
• Beule A, Athanasiadis T, Athanasiadis E, et al. Efficacy ofdifferent techniques of sinonasal irrigation after modified Lothrop procedure. Am J Rhinol Allergy. 2009 Jan-Feb;23(1):85–90.
   PubMed Web of Science ®Google Scholar
• Wei CC, Adappa ND, Cohen NA. Use of topical nasal therapies in the management of chronic rhinosinusitis. Laryngoscope. 2013 Oct;123(10):2347–2359. Epub 2013 Apr 1. Review. DOI:10.1002/lary.24066
   PubMed Web of Science ®Google Scholar
• Habib AR, Thamboo A, Manji J, et al. The effect of head position on the distribution of topical nasal medication using the Mucosal Atomization Device: a cadaver study. Int Forum Allergy Rhinol. 2013 Dec;3(12):958–962.
   PubMed Web of Science ®Google Scholar
• Head K, Chong LY, Hopkins C, et al. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016 Apr;26(4):CD011991. Review.
   Google Scholar
• Kennedy DW. The PROPEL™ steroid-releasing bioabsorbable implant to improve outcomes of sinus surgery. Expert Rev Respir Med. 2012 Nov;6(5):493-498. doi: 10.1586/ers.12.53. Review.
   PubMed Web of Science ®Google Scholar
• Ferguson BJ, Otto BA, Pant H. When surgery, antibiotics, and steroids fail to resolve chronic rhinosinusitis. Immunol Allergy Clin North Am. 2009;29(4):719–732.
   PubMed Web of Science ®Google Scholar
• Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind,randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope. 2006 Feb;116(2):189–193.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan VR, Hauser LJ, Frank DN. The sinonasal bacterial microbiome inhealth and disease. Curr Opin Otolaryngol Head Neck Surg. 2016 Feb;24(1):20–25. Review.
   PubMed Web of Science ®Google Scholar
• Murr AH, Smith TL, Hwang PH, et al. Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int Forum Allergy Rhinol. 2011 Jan-Feb;1(1):23–32. Pub 2011 Feb 8.
   PubMed Web of Science ®Google Scholar
• Forwith KD, Chandra RK, Yun PT, et al. ADVANCE: a multisitetrial of bioabsorbable steroid-eluting sinus implants. Laryngoscope. 2011 Nov;121(11):2473–2480.
   PubMed Web of Science ®Google Scholar
• Marple BF, Smith TL, Han JK, et al. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg. 2012 Jun;146(6):1004–1011.
   PubMed Web of Science ®Google Scholar
• Han JK, Marple BF, Smith TL, et al. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis. Int Forum Allergy Rhinol. 2012 Jul-Aug;2(4):271–279. Epub 2012 May 1.
   PubMed Web of Science ®Google Scholar
• Smith TL, Singh A, Luong A, et al. Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening. Laryngoscope. 2016 Jul 1;126:2659–2664.
   PubMed Web of Science ®Google Scholar
• Lee JT, Han JK. Sinus implants for chronic rhinosinusitis: technology evaluation. Expert Opin Drug Deliv. 2013 Dec;10(12):1735–1748. Epub 2013 Oct 3. Review. DOI:10.1517/17425247.2013.839654
   PubMed Web of Science ®Google Scholar
• Rudmik L, Smith TL. Economic evaluation of a steroid-eluting sinus implantfollowing endoscopic sinus surgery for chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2014 May 5;151(2):359–366. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Rizzo JA, Rudmik L, Mallow PJ, et al. Budget impact analysis ofbioabsorbable drug-eluting sinus implants following endoscopic sinus surgery. J Med Econ. 2016 Sep;19(9):829–835.
   PubMed Web of Science ®Google Scholar
• Janisiewicz A, Lee JT. In-office use of a steroid-eluting implant formaintenance of frontal ostial patency after revision sinus surgery. Allergyrhinol (Providence). 2015 Jan;6(1):68–75. Epub 2015 Feb 9. DOI:10.2500/ar.2015.6.0104
   PubMed Web of Science ®Google Scholar
• Massey CJ, Suh JD, Tessema B, et al. Biomaterials in rhinology. Otolaryngol Head Neck Surg. 2016 Apr;154(4):606–617. Epub 2016 Feb 23. Review. Erratum in: Otolaryngol Head Neck Surg. 2016 Oct; 155(4):718.Oto laryngol Head Neck Surg. 2016 Apr; 154(4):617. DOI:10.1177/0194599815627782
   PubMed Web of Science ®Google Scholar
• Chang EH, Alandejani T, Akbari E, et al. Double-blinded, randomized, controlled trial of medicated versus nonmedicated merocel sponges for functional endoscopic sinus surgery. J Otolaryngol Head Neck Surg. 2011;40(suppl 1):S14–S19.
   PubMedGoogle Scholar
• Rudmik L, Mace J, Mechor B. Effect of a dexamethasone Sinu-Foam™ middle meatal spacer on endoscopic sinus surgery outcomes: a randomized, double-blind, placebocontrolled trial. Int Forum Allergy Rhinol. 2012;2:248–251.
   PubMed Web of Science ®Google Scholar
• Côté DW, Wright ED. Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study. Laryngoscope. 2010;120:1269–1273.
   PubMed Web of Science ®Google Scholar
• Kosoglou T, Hubbell J, Cutler DL, et al. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler. Chest. 2013 Dec;144(6):1795–1802.
   PubMed Web of Science ®Google Scholar
• Bruni FM, De Luca G, Venturoli V, et al. Intranasal corticosteroids and adrenal suppression. Neuroimmunomodulation. 2009;16(5):353–362.
   PubMed Web of Science ®Google Scholar
• Demoly P. Safety of intranasal corticosteroids in acute rhinosinusitis. Am J Otolaryngol. 2008 Nov-Dec;29(6):403–413.
   PubMed Web of Science ®Google Scholar
• Zitt M, Kosoglou T, Hubbell J. Mometasone furoate nasal spray: a review of safety and systemic effects. Drug Saf. 2007;30(4):317–326. Review.
   PubMed Web of Science ®Google Scholar
• Nayak AS, Settipane GA, Pedinoff A, et al.; Nasonex Sinusitis Group. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol. 2002 Sep;89(3):271–278.
   PubMed Web of Science ®Google Scholar
• Boner AL. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children. J Allergy Clin Immunol. 2001 Jul;108(1 Suppl):S32–9.
   PubMed Web of Science ®Google Scholar
• Affrime MB, Kosoglou T, Thonoor CM, et al. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses. Chest. 2000 Dec;118(6):1538–1546.
   PubMed Web of Science ®Google Scholar
• Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000 Feb;105(2):e22–e22.
   PubMed Web of Science ®Google Scholar
• Li PM, Downie D, Hwang PH. Controlled steroid delivery via bioabsorbable stent: safety and performance in a rabbit model. Am J Rhinol Allergy. 2009 Nov-Dec;23(6):591–596. Erratum in: Am J RhinolAllergy. 2010 Mar;24(2):165. Li, Peter F. DOI:10.2500/ajra.2009.23.3391
   PubMed Web of Science ®Google Scholar